Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
2020 · EClinicalMedicine · 248 citations
https://doi.org/10.1016/j.eclinm.2019.100249
S
Shirley H. J. Mei
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
119
Papers
4.1K
Citations
28
h-index
43
i10-index
Shirley H. J. Mei is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Mesenchymal stem cell research & Neonatal Respiratory Health Research & Respiratory Support and Mechanisms. The author has an h-index of 28, co-authored 102 publications.
ORCID: 0000-0003-4727-1177Papers by this author
worksMesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury
2021 · European Respiratory Journal · 77 citations
https://doi.org/10.1183/13993003.04216-2020
Occlusive Lung Arterial Lesions in Endothelial-Targeted, Fas-Induced Apoptosis Transgenic Mice
2015 · American Journal of Respiratory Cell and Molecular Biology · 33 citations
https://doi.org/10.1165/rcmb.2014-0311oc
Gene engineered mesenchymal stem cells: greater transgene expression and efficacy with minicircle vs. plasmid DNA vectors in a mouse model of acute lung injury
2021 · Stem Cell Research & Therapy · 31 citations
https://doi.org/10.1186/s13287-021-02245-5
Death Associated Protein Kinase (DAPK) -mediated neurodegenerative mechanisms in nematode excitotoxicity
2015 · BMC Neuroscience · 20 citations
https://doi.org/10.1186/s12868-015-0158-2
Poly(I:C) enhances mesenchymal stem cell control of myeloid cells from COVID-19 patients
2022 · iScience · 10 citations
https://doi.org/10.1016/j.isci.2022.104188
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat